Results 31 to 40 of about 4,685 (255)

Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study [PDF]

Korean Journal of Anesthesiology, 2023
Background Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown.
Yuji Suzuki, Shingo Kawashima, Hiroshi Makino, Matsuyuki Doi, Yoshiki Nakajima   +4 more
doaj   +1 more source

Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system [PDF]

, 2019
Background: Remimazolam is an ultra-short acting benzodiazepine under development for procedural sedation and general anesthesia. It is hydrolyzed by CES1 to an inactive metabolite (CNS7054).
Damm, Georg, Freyer, Nora, Greuel, Selina, Knöspel, Fanny, Petersen, Karl-Uwe, Schneider, Christin, Seehofer, Daniel, Stöhr, Thomas, Zeilinger, Katrin   +8 more
core   +1 more source

Clinical Application and Research Progress of Remimazolam for Pediatric Patients

Drug Design, Development and Therapy
Chen Bai, Mingcan Xu, Yan Guo, Yanwu Jin, Xin Zhao Department of Anesthesiology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of ChinaCorrespondence: Yanwu Jin; Xin Zhao, Department of ...
Chen Bai, Yanwu Jin, Xin Zhao
exaly   +2 more sources

Real-World Evaluation of Remimazolam for Sedation During Gastrointestinal Endoscopy: Efficacy, Safety, and Risk Factors. [PDF]

JGH Open
ABSTRACT Background and Aim Remimazolam is a benzodiazepine receptor agonist intravenous anesthetic. This study aimed to evaluate the efficacy and safety of remimazolam for sedation during gastrointestinal endoscopy using real‐world clinical data.
Sakurai H, Miyazaki K, Nakayama A, Sasaki M, Oowada M, Sugawara M, Kubo Y, Mizobe R, Katsumi A, Ishizawa M, Imura Y, Murata S, Minezaki D, Iwata K, Tojo A, Masunaga T, Kirita K, Mizutani M, Nishikawa M, Takatori Y, Akimoto T, Kawasaki S, Matsuura N, Tomida H, Sujino T, Takabayashi K, Takanori K, Yahagi N, Kato M.   +28 more
europepmc   +2 more sources

Advantages of Intravenous Administration of Remimazolam Over Midazolam in Inflammatory Bowel Disease Patients Undergoing Endoscopic Procedures: An Educational Module [PDF]

, 2023
Background: Inflammatory bowel disease (IBD) patients experience more pain and discomfort during colonoscopy due to the nature of the disease. They are often young, highly anxious before the procedure, and have undergone many previous colonoscopies ...
Gil, Jillian, Perez, Alexis, Valdes, Jorge   +2 more
core   +1 more source

Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study [PDF]

Korean Journal of Anesthesiology
Background Minimalist transcatheter aortic valve replacement (TAVR) under monitored anesthesia care (MAC) emphasizes early recovery. Remimazolam is a novel benzodiazepine with a short recovery time.
Ji-Hyeon Kim, Jae-Sik Nam, Wan-Woo Seo, Kyung-Woon Joung, Ji-Hyun Chin, Wook-Jong Kim, Dae-Kee Choi, In-Cheol Choi   +7 more
doaj   +1 more source

What's New in Intravenous Anaesthesia?:New Hypnotics, New Models and New Applications [PDF]

, 2022
New anaesthetic drugs and new methods to administer anaesthetic drugs are continually becoming available, and the development of new PK-PD models furthers the possibilities of using arget controlled infusion (TCI) for anaesthesia.
Absalom, Anthony R, Barends, Clemens R M, Struys, Michel M R F, Valk, Beatrijs I, Vellinga, Remco   +4 more
core   +1 more source

Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report

JA Clinical Reports, 2021
Background Remimazolam has less cardiovascular depressant effects than propofol in non-cardiac surgical patients. However, the efficacy and safety of remimazolam in cardiac surgery with cardiopulmonary bypass (CPB) have not been reported.
Kota Saito, Sho Ohno, Makishi Maeda, Naoyuki Hirata, Michiaki Yamakage   +4 more
doaj   +1 more source

Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report

JA Clinical Reports, 2022
Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis.
Satoshi Uchida, Daiki Takekawa, Eiji Hashiba, Reiko Kudo, Kazuyoshi Hirota   +4 more
doaj   +1 more source

Anesthesia Management of a Liver Transplant Recipient with Remimazolam

Case Reports in Anesthesiology, 2023
Background. Intraoperative anesthetic requirements might be altered due to the modulated metabolic function in living donor liver transplant recipients. Remimazolam may provide appropriate anesthesia in patients with cirrhosis.
Takashi Kawasaki, Takafumi Oyoshi, Naoyuki Hirata   +2 more
doaj   +1 more source